Home / Simcyp

Tag: Simcyp

Certara Awarded FDA Grant to Further Advance Virtual Bioequivalence Assessments of Generic Medicines Using Biosimulation

By

Represents Fourth FDA Grant for Simcyp MechDermA Model for Virtual Bioequivalence PRINCETON, N.J.— September 20, 2021. Certara (Nasdaq: CERT), a global leader in biosimulation, today announced the Company has been awarded a grant from the U.S. Food and Drug Administration (FDA) to verify and expand biosimulation models for assessing virtual bioequivalence (VBE) to help enable … Continued

Essentials of Model-informed Drug Development (MIDD) – Top-down vs. Bottom-up Approaches

By

How can the latest modeling and simulation technologies accelerate drug discovery and development? We frequently receive questions about why model-informed drug development (MIDD) is so critical to informing the development of safer and more effective new drugs? Indeed, all drug discovery and development today involves some level of MIDD, a term that encompasses a large … Continued

Certara’s Simcyp™ COVID-19 Vaccine Model Named Finalist in Both the 2021 Citeline Awards and R&D 100 Awards

By

PRINCETON, NJ – August 26, 2021 – Certara, a global leader in biosimulation, today announced that its Simcyp COVID-19 Vaccine Model has been named a finalist in both Informa Pharma Intelligence’s 2021 Citeline Awards in the Excellence in Innovation in Response to COVID-19 – Clinical Trial Activities category and R&D World’s 2021 R&D 100 Awards … Continued

1 of 36
Back to top
Powered by Translations.com GlobalLink OneLink Software